Gleevec, Novartis Leukemia Drug Could Lead to Alzheimer’s Treatment If…
Posted on September 2, 2010 by Jeffrey Newman
Some new research reported in the Journal Nature this week and highlighted in the New York Times, suggests that an existing drug used for leukemia could prevent the growth of beta amyloid, thought to cause Alzheimer’s disease. The problem is that when tested in animals, the drug Gleevec does not remain in the brain long […]